Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Strong statin therapy reverses plaque build-up in arteries

24.09.2002


Reducing bad cholesterol to below "optimal" levels reversed the accumulation of artery-clogging plaque, according to a study in today’s rapid access issue of Circulation: Journal of the American Heart Association. When atherosclerotic plaque builds up in the arteries it can cause a heart attack or stroke.



People with known heart disease or a major risk factor, such as diabetes, are counseled to reduce their low-density lipoprotein (LDL) cholesterol ("bad" cholesterol) below 100 milligrams/deciliter (mg/dL) of blood. The goal for patients whose only risk factor is high cholesterol is usually below 130 mg/dL. Statin drugs are commonly used to lower total and LDL cholesterol.

There has been some question recently, however, whether more aggressive LDL lowering would confer an even greater benefit, says lead author Allen J. Taylor, M.D., director of cardiovascular research at Walter Reed Army Medical Center in Washington, D.C.


In addition, there is a question of whether factors besides cholesterol-lowering figure into the overall benefit from statin therapy. Besides affecting cholesterol, statins may also affect levels of inflammation or the degree of artery thickening.

"This is the first comparison of two statin drugs in a general population that looked at more than their cholesterol-lowering abilities," says Taylor.

Researchers recruited 161 patients (average age 60, 71 percent men) who were candidates for statin therapy. About half had known cardiovascular disease. Of these patients, 138 completed the study in which they received either 40 milligrams (mg) of the natural drug pravastatin, or 80 mg of relatively new synthetic statin called atorvastatin.

After 12 months, those receiving pravastatin treatment had a 27.5 percent drop in their LDL cholesterol compared to a 48.5 percent reduction in LDL for people treated with the higher dose of atorvastatin. The pravastatin group’s LDL was reduced to 110 mg/dL while the atorvastatin group’s LDL level was 76 mg/dL.

Researchers used ultrasound to compare the thickness of the carotid arteries (major arteries in the neck that supply blood to the brain) before treatment, after six months, and after one year of therapy. The amount of plaque in the carotid arteries is considered a good indicator of the amount of atherosclerosis throughout the body.

The researchers found that many patients had a net decrease in carotid artery thickness – 54 percent of atorvastatin patients and 39 percent of pravastatin patients.

Patients who received moderate treatment with pravastatin showed a slight progression in the thickness of the atherosclerosis in their carotid arteries (from an average of .615 mm at baseline to an average of .640 mm thickness at 12 months). Those who received atorvastatin treatment had a decrease (from an average of .625 mm to an average of .591 mm).

"Atherosclerosis is a progressive disease that takes years to develop and continues to get worse over time unless treated," Taylor explains. "Previous studies found that patients in whom plaque stabilized – or stopped progressing – had the lowest risk of heart attacks and other cardiovascular disease problems. In general, past studies have shown that regression is uncommon."

"We need to carefully define at what point lower LDL values have the greatest benefit in lowering the risk of heart disease. This study would suggest that LDL values much lower than 100 mg/dL appears better than a value of around 100," he says.

In an accompanying editorial, Prediman K. Shah, M.D., director of the division of cardiology and atherosclerosis research center at Cedars Sinai Medical Center in Los Angeles, Calif., says, "The data provided by Taylor are of potential interest and could have significant implications for clinical practice. However, before we conclude that more LDL-lowering means less atherosclerosis progression or clinical events, more in depth research is necessary."

Shah points to several large scale trials that are measuring the effect of moderate vs. aggressive cholesterol lowering on coronary plaque and cardiac events that should provide additional valuable information in the near future.


Co-authors include Steven M. Kent, M.D.; Patrick J. Flaherty, D.O.; Louis C. Coyle, D.O.; Thor T. Markwood M.D.; and Marina N. Vernalis, D.O.

CONTACT: For journal copies only,
please call: (214) 706-1396
For other information, call:
Carole Bullock: (214) 706-1279
Bridgette McNeill: (214) 706-1135

Carole Bullock | EurekAlert!
Further information:
http://www.americanheart.org/

More articles from Health and Medicine:

nachricht TSRI researchers develop new method to 'fingerprint' HIV
29.03.2017 | Scripps Research Institute

nachricht Periodic ventilation keeps more pollen out than tilted-open windows
29.03.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Researchers shoot for success with simulations of laser pulse-material interactions

29.03.2017 | Materials Sciences

Igniting a solar flare in the corona with lower-atmosphere kindling

29.03.2017 | Physics and Astronomy

As sea level rises, much of Honolulu and Waikiki vulnerable to groundwater inundation

29.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>